Viewing Study NCT01233232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:32 PM
Ignite Modification Date: 2026-01-10 @ 7:12 PM
Study NCT ID: NCT01233232
Status: COMPLETED
Last Update Posted: 2015-09-17
First Post: 2010-11-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A 4 Week Study to Investigate the Safety and Tolerability of AZD5069 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Scientific Terminology Chronic Obstructive Pulmonary Disease (COPD) View
None Laymen Terminology Chronic Bronchitis and Emphysema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Chronic Obstructive Pulmonary Disease, Neutrophil, Respiratory Disease View